| product Name |
betamethasone 17,21-dipropionate |
| Synonyms |
BETA METHASONE DIPROPIONATE; Betamethasone Dipropionate; BETAMETHASONE 17,21-DI-PROPIONATE; BETAMETHASONE 17-ALPHA,21-DIPROPIONATE; 1,4-PREGNADIEN-9-ALPHA-FLUORO-16-BETA-METHYL-11-BETA, 17,21-TRIOL-3,20-DIONE 17,21-DIPROPIONATE; 9ALPHA-FLUORO-16BETA-METHYL-11BETA,17ALPHA,21-TRIHYDROXY-1,4-PREGNADIENE-3,20-DIONE 17,21-DIPROPIONATE; 9a-fluoro-16b-methyl-11b,17a,21-trihydroxy-1,4-pregnadiene-3,20-dione 17,21-dipropionate; diproderm; diprolene; diprosis; diprosone; 9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate); Betanmethasone Dipronate; Pregna-1,4-Diene-3,20-Dione,9-Fluoro-11-Hydroxy-16-Methyl-17,21-Bis(1-Oxopropoxy)-,(11Beta,16Beta)-
(11-beta,16-beta)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione-17,21-dipropionate; Betamethasonediproprionate; 9--Fluoro-16--methyl-11,17,21-trihydroxy-1,4-pregnadiene-3,20-dione17,21-dipropionate; BETANMETHASONE DIPROPIONATE; BETAMETHASONEDIPROPIONATE,MICRONIZEDPOWDER,USP; Diprophos; Maxivate; (11beta,16beta)-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate; (8xi,9xi,11beta,14xi,16beta)-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate; (9ξ,11β,16β)-17-[(chloroacetyl)oxy]-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl propanoate |
| Molecular Formula |
C27H34ClFO7 |
| Molecular Weight |
525.0061 |
| InChI |
InChI=1/C27H34ClFO7/c1-5-22(33)35-14-21(32)27(36-23(34)13-28)15(2)10-19-18-7-6-16-11-17(30)8-9-24(16,3)26(18,29)20(31)12-25(19,27)4/h8-9,11,15,18-20,31H,5-7,10,12-14H2,1-4H3/t15-,18-,19-,20-,24-,25-,26?,27-/m0/s1 |
| CAS Registry Number |
5593-20-4 |
| EINECS |
227-005-2 |
| Molecular Structure |
|
| Density |
1.31g/cm3 |
| Boiling point |
622.9°C at 760 mmHg |
| Refractive index |
1.559 |
| Flash point |
330.5°C |
| Vapour Pressur |
3.97E-18mmHg at 25°C |
| Hazard Symbols |
|
| Risk Codes |
|
| Safety Description |
|
|
